236 related articles for article (PubMed ID: 22541411)
1. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
[TBL] [Abstract][Full Text] [Related]
2. The use of standardized extracts in allergen immunotherapy.
Nelson HS
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303
[TBL] [Abstract][Full Text] [Related]
3. Allergen immunotherapy practice patterns: a worldwide survey.
Ponda P; Mithani S; Kopyltsova Y; Sison C; Gupta P; Larenas D; Bonagura VR
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):454-459.e7. PubMed ID: 22626600
[TBL] [Abstract][Full Text] [Related]
4. Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993-2009.
Robertson BD; McCoy RL; Nelson MR; Haymore BR
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):437-40. PubMed ID: 22018616
[TBL] [Abstract][Full Text] [Related]
5. Perception and practice of sublingual immunotherapy among practicing allergists.
Tucker MH; Tankersley MS;
Ann Allergy Asthma Immunol; 2008 Oct; 101(4):419-25. PubMed ID: 18939732
[TBL] [Abstract][Full Text] [Related]
6. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.
Grier TJ
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):201-5. PubMed ID: 22374205
[TBL] [Abstract][Full Text] [Related]
7. Dose adjustment practices among allergists for local reactions to immunotherapy.
Coop CA; Tankersley MS
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
[TBL] [Abstract][Full Text] [Related]
8. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
[TBL] [Abstract][Full Text] [Related]
9. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
Cox L; Jacobsen L
Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
[TBL] [Abstract][Full Text] [Related]
10. The optimal immunotherapy cluster schedule in clinical practice.
Fernández-Távora L; Moreno C; Martín S; Rico P
J Investig Allergol Clin Immunol; 2003; 13(3):193-201. PubMed ID: 14635470
[TBL] [Abstract][Full Text] [Related]
11. Allergen immunotherapy at university health services and allergist's reasons for guidelines nonadherence.
Karam M; Holland C; Yang Z; Samuels K; Sanders G
Allergy Asthma Proc; 2017 Mar; 38(2):115-120. PubMed ID: 28234048
[TBL] [Abstract][Full Text] [Related]
12. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report.
Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA
J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595
[TBL] [Abstract][Full Text] [Related]
13. Dose Adjustment After Gaps in Administration of Subcutaneous Immunotherapy From a Past Survey: Work Group Report of the AAAAI Allergen Standardization and Allergy Diagnostics Committee.
Larenas-Linnemann D; Ponda P; Creticos P; Bernstein D; Epstein T; Williams P
J Allergy Clin Immunol Pract; 2023 Jan; 11(1):145-148.e4. PubMed ID: 36443172
[TBL] [Abstract][Full Text] [Related]
14. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey.
Sikora JM; Tankersley MS;
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):194-197.e4. PubMed ID: 23548531
[TBL] [Abstract][Full Text] [Related]
15. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
16. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
Malling HJ
Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
[TBL] [Abstract][Full Text] [Related]
17. American Academy of Allergy, Asthma & Immunology membership experience with allergen immunotherapy safety in patients with specific medical conditions.
Larenas-Linnemann DE; Hauswirth DW; Calabria CW; Sher LD; Rank MA
Allergy Asthma Proc; 2016 Sep; 37(5):112-22. PubMed ID: 27657518
[TBL] [Abstract][Full Text] [Related]
18. European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.
Calderón MA; Larenas D; Kleine-Tebbe J; Jacobsen L; Passalacqua G; Eng PA; Varga EM; Valovirta E; Moreno C; Malling HJ; Alvarez-Cuesta E; Durham S; Demoly P
Allergy; 2011 Oct; 66(10):1345-59. PubMed ID: 21707645
[TBL] [Abstract][Full Text] [Related]
19. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics.
Jutel M; Agache I; Bonini S; Burks AW; Calderon M; Canonica W; Cox L; Demoly P; Frew AJ; O'Hehir R; Kleine-Tebbe J; Muraro A; Lack G; Larenas D; Levin M; Martin BL; Nelson H; Pawankar R; Pfaar O; van Ree R; Sampson H; Sublett JL; Sugita K; Du Toit G; Werfel T; Gerth van Wijk R; Zhang L; Akdis M; Akdis CA
J Allergy Clin Immunol; 2016 Feb; 137(2):358-68. PubMed ID: 26853128
[TBL] [Abstract][Full Text] [Related]
20. Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units.
Larenas-Linnemann D; Esch R; Plunkett G; Brown S; Maddox D; Barnes C; Constable D
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):448-458.e3. PubMed ID: 22018618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
